Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 128

1.

Plasma levels of matrix metalloproteinase-2, -3, -10, and tissue inhibitor of metalloproteinase-1 are associated with vascular complications in patients with type 1 diabetes: the EURODIAB Prospective Complications Study.

Peeters SA, Engelen L, Buijs J, Chaturvedi N, Fuller JH, Schalkwijk CG, Stehouwer CD; EURODIAB Prospective Complications Study Group.

Cardiovasc Diabetol. 2015 Mar 10;14:31. doi: 10.1186/s12933-015-0195-2.

2.

Do European people with type 1 diabetes consume a high atherogenic diet? 7-year follow-up of the EURODIAB Prospective Complications Study.

Soedamah-Muthu SS, Chaturvedi N, Fuller JH, Toeller M; EURODIAB Prospective Complications Study Group.

Eur J Nutr. 2013 Oct;52(7):1701-10. doi: 10.1007/s00394-012-0473-7. Epub 2012 Dec 7.

PMID:
23224030
3.

Unhealthy dietary patterns associated with inflammation and endothelial dysfunction in type 1 diabetes: the EURODIAB study.

van Bussel BC, Soedamah-Muthu SS, Henry RM, Schalkwijk CG, Ferreira I, Chaturvedi N, Toeller M, Fuller JH, Stehouwer CD; EURODIAB Prospective Complications Study Group.

Nutr Metab Cardiovasc Dis. 2013 Aug;23(8):758-64. doi: 10.1016/j.numecd.2012.04.005. Epub 2012 Jul 12.

PMID:
22795869
4.

Dietary saturated fat and fibre and risk of cardiovascular disease and all-cause mortality among type 1 diabetic patients: the EURODIAB Prospective Complications Study.

Schoenaker DA, Toeller M, Chaturvedi N, Fuller JH, Soedamah-Muthu SS; EURODIAB Prospective Complications Study Group.

Diabetologia. 2012 Aug;55(8):2132-41. doi: 10.1007/s00125-012-2550-0. Epub 2012 Apr 12.

5.

Serum high-mobility group box-1 levels are positively associated with micro- and macroalbuminuria but not with cardiovascular disease in type 1 diabetes: the EURODIAB Prospective Complications Study.

Nin JW, Ferreira I, Schalkwijk CG, Prins MH, Chaturvedi N, Fuller JH, Stehouwer CD; EURODIAB Prospective Complications Study Group.

Eur J Endocrinol. 2012 Feb;166(2):325-32. doi: 10.1530/EJE-11-0662. Epub 2011 Nov 29.

6.

In vitro effects of Choukroun's platelet-rich fibrin conditioned medium on 3 different cell lines implicated in dental implantology.

Clipet F, Tricot S, Alno N, Massot M, Solhi H, Cathelineau G, Perez F, De Mello G, Pellen-Mussi P.

Implant Dent. 2012 Feb;21(1):51-6. doi: 10.1097/ID.0b013e31822b9cb4.

PMID:
21986450
7.

Apatite forming ability and cytocompatibility of pure and Zn-doped bioactive glasses.

Oudadesse H, Dietrich E, Gal YL, Pellen P, Bureau B, Mostafa AA, Cathelineau G.

Biomed Mater. 2011 Jun;6(3):035006. doi: 10.1088/1748-6041/6/3/035006. Epub 2011 Apr 20.

PMID:
21505231
8.

Effect of hydroxyapatite and beta-tricalcium phosphate nanoparticles on promonocytic U937 cells.

Jeanne S, Tricot-Doleux S, Pellen-Mussi P, Perez F, Oudadesse H, Cathelineau G.

J Biomed Nanotechnol. 2010 Apr;6(2):158-65. Erratum in: J Biomed Nanotechnol. 2010 Aug;6(4):following 403. Sylvie, Jeanne [corrected to Jeanne, Sylvie]; Sylvie, Tricot-Doleux [corrected to Tricot-Doleux, Sylvie]; Pascal, Pellen-Mussi [corrected to Pellen-Mussi, Pascal]; Fabienne, Perez [corrected to Perez, Fabienne]; Hassane, Oudadesse [corrected to Oudadesse, Hassane]; Guy, Cathelineau [corrected to Cathelineau, Guy].

PMID:
20738070
9.

Development of a three-dimensional model for rapid evaluation of bone substitutes in vitro: effect of the 45S5 bioglass.

Alno N, Jegoux F, Pellen-Mussi P, Tricot-Doleux S, Oudadesse H, Cathelineau G, De Mello G.

J Biomed Mater Res A. 2010 Oct;95(1):137-45. doi: 10.1002/jbm.a.32818.

PMID:
20540096
10.

[Enamel micro-abrasion].

Mehdi S, Mano MC, Sorel O, Cathelineau G.

Orthod Fr. 2009 Jun;80(2):179-92. doi: 10.1051/orthodfr/2009012. Epub 2009 Jun 25. French.

11.

Comparison of the bony remodelling of two synthetic biomaterials: aragonite 55% and aragonite 55% with active substance.

Oudadesse H, Derrien AC, Martin S, Lucas-Girot A, Cathelineau G.

Biomed Mater. 2007 Mar;2(1):S65-70. doi: 10.1088/1748-6041/2/1/S10. Epub 2007 Mar 2.

PMID:
18458422
12.

Aluminosilicates and biphasic HA-TCP composites: studies of properties for bony filling.

Oudadesse H, Derrien AC, Mami M, Martin S, Cathelineau G, Yahia L.

Biomed Mater. 2007 Mar;2(1):S59-64. doi: 10.1088/1748-6041/2/1/S09. Epub 2007 Mar 2.

PMID:
18458421
13.

Relationship between risk factors and mortality in type 1 diabetic patients in Europe: the EURODIAB Prospective Complications Study (PCS).

Soedamah-Muthu SS, Chaturvedi N, Witte DR, Stevens LK, Porta M, Fuller JH; EURODIAB Prospective Complications Study Group.

Diabetes Care. 2008 Jul;31(7):1360-6. doi: 10.2337/dc08-0107. Epub 2008 Mar 28.

14.

Antibiotic cements in articular prostheses: current orthopaedic concepts.

Langlais F, Belot N, Ropars M, Thomazeau H, Lambotte JC, Cathelineau G.

Int J Antimicrob Agents. 2006 Aug;28(2):84-9. Epub 2006 Jun 22. Review.

PMID:
16797935
15.

Comparative study of two canal obturation techniques by image analysis and EDS microanalysis.

Guigand M, Glez D, Sibayan E, Cathelineau G, Vulcain JM.

Br Dent J. 2005 Jun 11;198(11):707-11, discussion 695.

PMID:
15951786
16.

Comparative study of manual and ultrasonic instrumentation of cementum surfaces: influence of lateral pressure.

Gagnot G, Mora F, Poblete MG, Vachey E, Michel JF, Cathelineau G.

Int J Periodontics Restorative Dent. 2004 Apr;24(2):137-45.

PMID:
15119884
17.

Characterisation and quantification of angiogenesis in beta-tricalcium phosphate implants by immunohistochemistry and transmission electron microscopy.

Henno S, Lambotte JC, Glez D, Guigand M, Lancien G, Cathelineau G.

Biomaterials. 2003 Aug;24(19):3173-81.

PMID:
12763444
18.

Comparison of bond strength between simple foil mesh and laser-structured base retention brackets.

Sorel O, El Alam R, Chagneau F, Cathelineau G.

Am J Orthod Dentofacial Orthop. 2002 Sep;122(3):260-6.

PMID:
12226606
19.

[Influence of the bonding interface on bracket adhesion].

Sorel O, Cathelineau G.

Orthod Fr. 2001 Dec;72(4):305-12. French.

PMID:
11820021
20.

Nutrient intakes as predictors of body weight in European people with type 1 diabetes.

Toeller M, Buyken AE, Heitkamp G, Cathelineau G, Ferriss B, Michel G; EURODIAB IDDM Complications Study Group.

Int J Obes Relat Metab Disord. 2001 Dec;25(12):1815-22.

PMID:
11781763
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk